Neuroone Medical Technologies (NMTC) Assets Average (2011 - 2026)

Neuroone Medical Technologies' Assets Average history runs 15 years deep, the most recent figure standing at $8.1 million for Q1 2026.

• Quarterly Assets Average rose 47.44% year-over-year to $8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (up 47.44% YoY) and the FY2025 annual result came in at $8.1 million, up 19.96% from the prior year.
• Assets Average was $8.1 million for Q1 2026 at Neuroone Medical Technologies, down from $9.7 million in the prior quarter.
• Across five years, Assets Average topped out at $15.6 million in Q1 2022 and bottomed at $5.1 million in Q3 2024.
• A 5-year average of $8.5 million and a median of $7.6 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average sank 49.48% — and 2025, when it jumped 110.11%.
• Neuroone Medical Technologies' Assets Average stood at $11.2 million in 2022, then tumbled by 38.09% to $7.0 million in 2023, then fell by 14.77% to $5.9 million in 2024, then surged by 63.2% to $9.7 million in 2025, then fell by 16.61% to $8.1 million in 2026.
• Business Quant data shows NMTC's Assets Average at $8.1 million in Q1 2026, $9.7 million in Q4 2025, and $10.8 million in Q3 2025.